Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:32 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1897–1920 of 6,925 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control, small Clear all

Conditions: Autism Spectrum Disorder
Interventions: Occupational Therapy Intervention; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 6 Years to 9 Years · Male only
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Pain, Opiate
Interventions: sufentanil; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 70 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Down Syndrome
Interventions: Hip Helpers home program; Other
Lead sponsor: University of St. Augustine for Health Sciences; Other
Eligibility: 3 Months to 15 Months
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 3
States / cities: San Marcos, California • Saint Augustine, Florida • Austin, Texas

Conditions: Blood Glucose Monitoring
Interventions: YES Bar; Other
Lead sponsor: Efforia, Inc; Industry
Eligibility: Not listed
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Inhalational Anthrax
Interventions: ETI-204, Placebo; Biological · Other
Lead sponsor: Elusys Therapeutics; Other
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Obesity
Interventions: PSD Veritas Collagen Matrix, Roux-en-Y gastric by-pass surgery with no buttress; Device · Procedure
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Metabolic Syndrome, Diabetes, Aging
Interventions: US, IW, CW; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 60 Years to 85 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Small Cell Lung Cancer
Interventions: M3814, Cisplatin, Etoposide; Drug
Lead sponsor: EMD Serono Research & Development Institute, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 16
States / cities: Mesa, Arizona • Santa Rosa, California • Whittier, California + 12 more

Conditions: Developmental Disability, Autism Spectrum Disorder, Down Syndrome, Cerebral Palsy
Interventions: Zumba High Tempo, Zumba Low Tempo; Behavioral
Lead sponsor: Auburn University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Healthy
Interventions: VBP15, Placebo; Drug
Lead sponsor: ReveraGen BioPharma, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Lenexa, Kansas

Conditions: High Blood Pressure, Hypertension
Interventions: Educational Intervention Based on Protection Motivation Theory to Improve Knowledge and Promote Nonpharmacological Approaches to Prevent and Manage Hypertension among Adults; Other
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Promoting Cardiovascular Health in Adults, Lifestyle Intervention, Atherosclerosis
Interventions: Intensive Individual Intervention Program, Peer-To-Peer Program Intervention; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 635 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 15
States / cities: New York, New York

Conditions: Muscle Atrophy
Interventions: Massage; Other
Lead sponsor: Esther Dupont-Versteegden; Other
Eligibility: 18 Years to 30 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Neuroblastoma, Cancer
Interventions: Biopsy, Next Generation Sequencing, Tumor Scans, Bone marrow Tests, Physical Exam, Eye Exam, Labs, Pregnancy Test, Interviews, ECG, Echocardiogram, Ribociclib, Ceritinib; Procedure · Genetic · Other + 2 more
Lead sponsor: Yael P Mosse; Other
Eligibility: 1 Year to 21 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Depression, Anxiety, Mental Disorders
Interventions: Thirty-Second Mindfulness Practice, Three-Minute Mindfulness Practice; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Body Weight
Interventions: Workout Window Reminders, Individual Workout Incentive Payment, Lump Incentive Payments, Partner Assignment; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 2,702 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Advanced Dementia
Interventions: Advance care planning intervention, Control group; Behavioral · Other
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 65 Years and older
Enrollment: 804 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma), NSCLC (Advanced Non-small Cell Lung Cancer)
Interventions: daraxonrasib, docetaxel; Drug
Lead sponsor: Revolution Medicines, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 590 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 53
States / cities: Birmingham, Alabama • Loma Linda, California • Long Beach, California + 43 more

Conditions: Nutrient Intake Inadequacy
Interventions: Indiana SNAP-Ed; Behavioral
Lead sponsor: Purdue University; Other
Eligibility: 18 Years and older
Enrollment: 261 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Contraception
Interventions: LARC Script; Behavioral
Lead sponsor: WakeMed Health and Hospitals; Other
Eligibility: 14 Years to 45 Years · Female only
Enrollment: 800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Raleigh, North Carolina

Conditions: Healthy
Interventions: Exercise; Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 20 Years to 40 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Non-small Cell Lung Cancer
Interventions: Standard Palliative Care Group, Integrated Palliative Care Intervention; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sarcoma, Bone, Sarcoma, Soft Tissue, Gait Disorder
Interventions: Lab based 3D Gait Assessment, Wearable Inertial Sensors (In Lab and Remote), Functional Testing & Patient Reported Outcomes, Remote Wearable Sensor Assessment; Diagnostic Test · Device · Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 5 Years to 20 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Venous Disease
Interventions: Custom-manufactured compression hosiery (Isobar), Off-the-rack stockings (Sigvaris); Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Sensory Intervention for Children With Autism

A Dosing and Efficacy Study of Intra-nasal Sufentanil for Moderate to Severe Pain

Impact of an Orthotic Garment on Gross Motor Skills for Infants With Down Syndrome

How Does YES Bar Affect Blood Glucose Levels?

Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers

Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas Collagen Matrix

Effects of Interrupting Sedentary Time on Glycemic Control in Older Overweight and Obese Adults

Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)

The Effects of Virtual Zumba® in Individuals With Developmental Disabilities

A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects

Using Nonpharmacological Approaches in Hypertension Prevention and Management

Family-based Approach to Promotion of Health - FAMILIA (Project 2)

Mechanisms Underlying Local and Systemic Effects of Massage

Next Generation Personalized Neuroblastoma Therapy

The Feasibility and Efficacy of an Extremely Brief Mindfulness Practice

Creating Exercise Habits Through Incentives for Routines

Educational Video to Improve Nursing Home Care in End-stage Dementia

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

The Indiana SNAP-Ed Long-term Study Sequel

Study of Birth Control Use After Childbirth

Effect of Exercise on Genes That Control Muscle Function

Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients

A Comparison of Custom-manufactured vs. Off-the-rack (OTR) Compression Hosiery for Initial Management of Venous Disease